Wei Xian Wu

Wei Xian Wu

Chief Executive Officer at DAWNRAYS PHARMACEUTICAL (HOLDINGS) LIMITED

Net worth: 298 980 $ as of 2024-03-30

55 year
Health Technology

Profile

Wei Xian Wu is currently the Chief Executive Officer at Dawnrays Pharmaceutical Holdings Ltd.
He is also a Director at Suzhou Dawnrays Pharmaceutical Co., Ltd., Fujian Dawnrays Pharmaceutical Co., Ltd., and Lanzhou Dawnrays Pharmaceutical Co. Ltd.
Previously, he was the General Manager & Director at Nanjing PharmaRays Science & Technology Co., Ltd.
and Guangzhou PharmaRays Science & Technology Co., Ltd.
He also worked as a Sales Manager at Beijing Novartis Pharma Ltd.
from 1997 to 2009.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2023-04-20 2,000,000 ( 0.13% ) 298 980 $ 2024-03-30

Wei Xian Wu active positions

CompaniesPositionStart
DAWNRAYS PHARMACEUTICAL (HOLDINGS) LIMITED Chief Executive Officer 2022-02-15
Suzhou Dawnrays Pharmaceutical Co., Ltd. Director/Board Member -
Lanzhou Dawnrays Pharmaceutical Co. Ltd. Director/Board Member -
Fujian Dawnrays Pharmaceutical Co., Ltd. Director/Board Member -
All active positions of Wei Xian Wu

Former positions of Wei Xian Wu

CompaniesPositionEnd
Sales & Marketing 2009-07-31
Nanjing PharmaRays Science & Technology Co., Ltd. Chief Executive Officer -
Guangzhou PharmaRays Science & Technology Co., Ltd. Chief Executive Officer -
See the detail of Wei Xian Wu's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Wei Xian Wu's experience

Connections

18

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies1
DAWNRAYS PHARMACEUTICAL (HOLDINGS) LIMITED

Health Technology

Private companies6
Suzhou Dawnrays Pharmaceutical Co., Ltd.

Health Technology

Fujian Dawnrays Pharmaceutical Co., Ltd.

Nanjing PharmaRays Science & Technology Co., Ltd.

Guangzhou PharmaRays Science & Technology Co., Ltd.

Lanzhou Dawnrays Pharmaceutical Co. Ltd.

See company connections